尿路癌治療薬の世界市場

【英語タイトル】Global Urological Cancer Therapeutics Drugs Sales Market Report 2017

QYResearchが出版した調査資料(QYR802A5666)・商品コード:QYR802A5666
・発行会社(調査会社):QYResearch
・発行日:2018年1月2日
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、尿路癌治療薬の世界市場について調査・分析し、尿路癌治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、尿路癌治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・尿路癌治療薬市場概要
・尿路癌治療薬のメーカー別販売量・メーカー別シェア
・尿路癌治療薬の世界市場:種類別販売量・市場シェア
・尿路癌治療薬の世界市場:用途別販売量・市場シェア
・尿路癌治療薬の世界市場:地域別販売量・市場シェア
・尿路癌治療薬のアメリカ市場規模
・尿路癌治療薬の中国市場規模
・尿路癌治療薬のヨーロッパ市場規模
・尿路癌治療薬の日本市場規模
・尿路癌治療薬の東南アジア市場規模
・尿路癌治療薬のインド市場規模
・尿路癌治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・尿路癌治療薬のコスト分析・価格動向
・尿路癌治療薬の産業チェーン(サプライチェーン分析)
・尿路癌治療薬のマーケティング戦略・販売チャネル、流通業者
・尿路癌治療薬市場への影響要因分析
・尿路癌治療薬の世界市場予測
・尿路癌治療薬のアメリカ市場予測
・尿路癌治療薬の中国市場予測
・尿路癌治療薬のヨーロッパ市場予測
・尿路癌治療薬の日本市場予測
・尿路癌治療薬の東南アジア市場予測
・尿路癌治療薬のインド市場予測
・尿路癌治療薬の種類別世界市場予測
・尿路癌治療薬の用途別世界市場予測
...
【レポートの概要】

In this report, the global Urological Cancer Therapeutics Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Urological Cancer Therapeutics Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Urological Cancer Therapeutics Drugs market competition by top manufacturers/players, with Urological Cancer Therapeutics Drugs sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline plc
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Xofigo (radium Ra 223 dichloride)
Jevtana (cabazitaxel)
Inlyta (axitinib)
Votrient (pazopanib hydrochloride)
Sutent (sunitinib malate)
Zytiga (abiraterone acetate)
Xtandi (enzalutamide)
Opdivo (nivolumab)
Provenge (sipuleucel-T)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Medical Research Laboratory
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Urological Cancer Therapeutics Drugs Sales Market Report 2017
1 Urological Cancer Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Urological Cancer Therapeutics Drugs
1.2 Classification of Urological Cancer Therapeutics Drugs by Product Category
1.2.1 Global Urological Cancer Therapeutics Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Urological Cancer Therapeutics Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Xofigo (radium Ra 223 dichloride)
1.2.4 Jevtana (cabazitaxel)
1.2.5 Inlyta (axitinib)
1.2.6 Votrient (pazopanib hydrochloride)
1.2.7 Sutent (sunitinib malate)
1.2.8 Zytiga (abiraterone acetate)
1.2.9 Xtandi (enzalutamide)
1.2.10 Opdivo (nivolumab)
1.2.11 Provenge (sipuleucel-T)
1.3 Global Urological Cancer Therapeutics Drugs Market by Application/End Users
1.3.1 Global Urological Cancer Therapeutics Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Global Urological Cancer Therapeutics Drugs Market by Region
1.4.1 Global Urological Cancer Therapeutics Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Urological Cancer Therapeutics Drugs Status and Prospect (2012-2022)
1.4.3 China Urological Cancer Therapeutics Drugs Status and Prospect (2012-2022)
1.4.4 Europe Urological Cancer Therapeutics Drugs Status and Prospect (2012-2022)
1.4.5 Japan Urological Cancer Therapeutics Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Urological Cancer Therapeutics Drugs Status and Prospect (2012-2022)
1.4.7 India Urological Cancer Therapeutics Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Urological Cancer Therapeutics Drugs (2012-2022)
1.5.1 Global Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

2 Global Urological Cancer Therapeutics Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Urological Cancer Therapeutics Drugs Market Competition by Players/Suppliers
2.1.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Urological Cancer Therapeutics Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Urological Cancer Therapeutics Drugs (Volume and Value) by Type
2.2.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Urological Cancer Therapeutics Drugs (Volume and Value) by Region
2.3.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Region (2012-2017)
2.3.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Urological Cancer Therapeutics Drugs (Volume) by Application

3 United States Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)
3.1 United States Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
3.1.1 United States Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
3.2 United States Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Players
3.3 United States Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
3.4 United States Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

4 China Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)
4.1 China Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
4.1.1 China Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
4.2 China Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Players
4.3 China Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
4.4 China Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

5 Europe Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)
5.1 Europe Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
5.1.1 Europe Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
5.2 Europe Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Players
5.3 Europe Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
5.4 Europe Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

6 Japan Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)
6.1 Japan Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
6.1.1 Japan Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
6.2 Japan Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Players
6.3 Japan Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
6.4 Japan Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

7 Southeast Asia Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

8 India Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)
8.1 India Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
8.1.1 India Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
8.2 India Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Players
8.3 India Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
8.4 India Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

9 Global Urological Cancer Therapeutics Drugs Players/Suppliers Profiles and Sales Data
9.1 Novartis
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Pfizer
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Johnson & Johnson
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 AstraZeneca
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Astellas
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Bristol-Myers Squibb
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Abbott Laboratories
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Celgene Corporation
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Dendreon Corporation
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Ferring Pharmaceuticals
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 GlaxoSmithKline plc
9.12 Indevus Pharmaceuticals Inc
9.13 Ipsen
9.14 Roche Healthcare
9.15 Sanofi S.A.

10 Urological Cancer Therapeutics Drugs Maufacturing Cost Analysis
10.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
10.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Urological Cancer Therapeutics Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Urological Cancer Therapeutics Drugs Market Forecast (2017-2022)
14.1 Global Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Urological Cancer Therapeutics Drugs Price and Trend Forecast (2017-2022)
14.2 Global Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2017-2022)
14.3.3 Global Urological Cancer Therapeutics Drugs Price Forecast by Type (2017-2022)
14.4 Global Urological Cancer Therapeutics Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Urological Cancer Therapeutics Drugs
Figure Global Urological Cancer Therapeutics Drugs Sales Volume Comparison (Units) by Type (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Xofigo (radium Ra 223 dichloride) Product Picture
Figure Jevtana (cabazitaxel) Product Picture
Figure Inlyta (axitinib) Product Picture
Figure Votrient (pazopanib hydrochloride) Product Picture
Figure Sutent (sunitinib malate) Product Picture
Figure Zytiga (abiraterone acetate) Product Picture
Figure Xtandi (enzalutamide) Product Picture
Figure Opdivo (nivolumab) Product Picture
Figure Provenge (sipuleucel-T) Product Picture
Figure Global Urological Cancer Therapeutics Drugs Sales Comparison (Units) by Application (2012-2022)
Figure Global Sales Market Share of Urological Cancer Therapeutics Drugs by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Research Laboratory Examples
Table Key Downstream Customer in Medical Research Laboratory
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Urological Cancer Therapeutics Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate (2012-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Urological Cancer Therapeutics Drugs Sales Volume (Units) (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Sales (Units) of Key Players/Suppliers (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Urological Cancer Therapeutics Drugs Sales Share by Players/Suppliers
Figure 2017 Urological Cancer Therapeutics Drugs Sales Share by Players/Suppliers
Figure Global Urological Cancer Therapeutics Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Urological Cancer Therapeutics Drugs Revenue Share by Players
Table 2017 Global Urological Cancer Therapeutics Drugs Revenue Share by Players
Table Global Urological Cancer Therapeutics Drugs Sales (Units) and Market Share by Type (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Sales Share (Units) by Type (2012-2017)
Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Sales Growth Rate by Type (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Sales Volume (Units) and Market Share by Region (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Sales Growth Rate by Region in 2016
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Revenue Growth Rate by Region in 2016
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Region (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region in 2016
Table Global Urological Cancer Therapeutics Drugs Sales Volume (Units) and Market Share by Application (2012-2017)
Table Global Urological Cancer Therapeutics Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Application (2012-2017)
Figure Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales Volume (Units) by Players (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players in 2016
Table United States Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table United States Urological Cancer Therapeutics Drugs Sales Volume (Units) by Application (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure China Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table China Urological Cancer Therapeutics Drugs Sales Volume (Units) by Players (2012-2017)
Table China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players in 2016
Table China Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table China Urological Cancer Therapeutics Drugs Sales Volume (Units) by Application (2012-2017)
Table China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure Europe Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Europe Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table Europe Urological Cancer Therapeutics Drugs Sales Volume (Units) by Players (2012-2017)
Table Europe Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players in 2016
Table Europe Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table Europe Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table Europe Urological Cancer Therapeutics Drugs Sales Volume (Units) by Application (2012-2017)
Table Europe Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure Japan Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Sales Volume (Units) by Players (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players in 2016
Table Japan Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table Japan Urological Cancer Therapeutics Drugs Sales Volume (Units) by Application (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume (Units) by Players (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume (Units) by Application (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure India Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table India Urological Cancer Therapeutics Drugs Sales Volume (Units) by Players (2012-2017)
Table India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Players in 2016
Table India Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table India Urological Cancer Therapeutics Drugs Sales Volume (Units) by Application (2012-2017)
Table India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Table Novartis Basic Information List
Table Novartis Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Novartis Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Pfizer Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure AstraZeneca Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Astellas Basic Information List
Table Astellas Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Astellas Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Dendreon Corporation Basic Information List
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales Growth Rate (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales Global Market Share (2012-2017
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table Indevus Pharmaceuticals Inc Basic Information List
Table Ipsen Basic Information List
Table Roche Healthcare Basic Information List
Table Sanofi S.A. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urological Cancer Therapeutics Drugs
Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure Urological Cancer Therapeutics Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Players in 2016
Table Major Buyers of Urological Cancer Therapeutics Drugs
Table Distributors/Traders List
Figure Global Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Price (K USD/Unit) and Trend Forecast (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Sales Volume (Units) Forecast by Regions (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure China Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Europe Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Sales (Units) Forecast by Type (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Price (K USD/Unit) Forecast by Type (2017-2022)
Table Global Urological Cancer Therapeutics Drugs Sales (Units) Forecast by Application (2017-2022)
Figure Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


★調査レポート[尿路癌治療薬の世界市場] (コード:QYR802A5666)販売に関する免責事項を必ずご確認ください。
★調査レポート[尿路癌治療薬の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆